Literature DB >> 24313862

Are melanomas averse to cerebellum? Cerebellar metastases in a surgical series.

S G Rogne1, E Helseth, P Brandal, D Scheie, T R Meling.   

Abstract

OBJECTIVES: To study the propensity of different cancers to metastasize to the cerebrum and cerebellum, and to study overall survival (OS) and prognostic factors for patients after surgical resection for cerebellar metastases.
MATERIALS AND METHODS: From a prospectively collected tumor database, all patients that underwent a craniotomy for intracranial metastases between 2003 and 2011 at Oslo University Hospital were included.
RESULTS: One hundred and forty patients underwent resection for cerebellar metastases. Most common primary tumor sites were lung, colon/rectum, and breast in 45%, 19%, and 14%, respectively. None were prostate cancers. Melanoma metastases were significantly underrepresented, and colorectal cancer metastases significantly overrepresented in cerebellum, compared to the overall proportion of cerebellar/supratentorial metastases surgically resected (P < 0.05). Thirty-day post-operative mortality rate was 4.3%. Median OS was 7.7 months (95% CI 6.0-9.5 months) irrespective of post-operative adjuvant therapy. Median OS was 51.8, 8.4, and 3.4 months, respectively, for recursive partitioning analysis class 1(n = 11), 2 (n = 78) and 3 (n = 34). Significant negative prognostic factors were age ≥65 years, Karnofsky performance score (KPS) <70, extracranial metastases and uncontrolled systemic disease.
CONCLUSIONS: Melanoma metastases were significantly underrepresented in cerebellum, whereas colorectal cancer metastases were significantly overrepresented. Surgical mortality and OS after surgical treatment of cerebellar metastases were similar to the results of supratentorial metastases.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  brain metastases; brain tumor surgery; cerebellar metastases; colorectal cancer; malignant melanoma

Mesh:

Year:  2013        PMID: 24313862     DOI: 10.1111/ane.12206

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  4 in total

1.  Edema is not a reliable diagnostic sign to exclude small brain metastases.

Authors:  Tanja Schneider; Jan Felix Kuhne; Paul Bittrich; Julian Schroeder; Tim Magnus; Malte Mohme; Malte Grosser; Gerhard Schoen; Jens Fiehler; Susanne Siemonsen
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

2.  The Infratentorial Localization of Brain Metastases May Correlate with Specific Clinical Characteristics and Portend Worse Outcomes Based on Voxel-Wise Mapping.

Authors:  Zhangqi Dou; Jiawei Wu; Hemmings Wu; Qian Yu; Feng Yan; Biao Jiang; Baizhou Li; Jinghong Xu; Qi Xie; Chenguang Li; Chongran Sun; Gao Chen
Journal:  Cancers (Basel)       Date:  2021-01-17       Impact factor: 6.639

Review 3.  Anatomical and topographical variations in the distribution of brain metastases based on primary cancer origin and molecular subtypes: a systematic review.

Authors:  Tyler Cardinal; Dhiraj Pangal; Ben A Strickland; Paul Newton; Saeedeh Mahmoodifar; Jeremy Mason; David Craig; Thomas Simon; Ben Yi Tew; Min Yu; Wensha Yang; Eric Chang; Ryan P Cabeen; Jacob Ruzevick; Arthur W Toga; Josh Neman; Bodour Salhia; Gabriel Zada
Journal:  Neurooncol Adv       Date:  2021-11-18

4.  Novel human melanoma brain metastasis models in athymic nude fox1nu mice: Site-specific metastasis patterns reflecting their clinical origin.

Authors:  Henrik A Svendsen; Torstein R Meling; Vigdis Nygaard; Stein Waagene; Hege Russnes; Siri Juell; Siril G Rogne; Jens Pahnke; Eirik Helseth; Øystein Fodstad; Gunhild M Maelandsmo
Journal:  Cancer Med       Date:  2021-10-06       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.